Abstract:Introduction: A major requirement in bone tissue engineering is the persistent and robust promotion of osteogenesis, which requires sustained stimulation with osteoinductive factors, such as bone morphogenetic protein-2 (BMP-2). However, the direct application of these factors remains challenging due to their short half-life and rapid systemic clearance. Given the well demonstrated benefits of recombinant adeno-associated viral (rAAV) vector, including long-term gene transfer efficiency and relative safety, rAAV-based therapies have been developed in both basic and translational research. However, traditional ex vivo gene transduction process is time consuming and requires multiple steps of cell culture. In addition, rAAV shows inconsistent transfection efficacy in primary cells. In this study, we co-packed rAAV-BMP-2 and human bone marrow stem cells (hBMSCs) into a gelatin scaffolds through one-step visible light-based phtocorsslinking (PXL), and tested their application for bone regenerationi. We hypothesize that the concentrated and localized release of rAAV-BMP-2 from the scaffold matrix results in higher transfection efficacy and BMP-2 expression in hBMSCs seeded within the scaffolds, thus enhancing their osteogenic differentiation and bone formation upon implantation in bone defect. Methods: hBMSCs were obtained with IRB approval from total joint arthroplasty patient. The rAAV6-BMP-2 and rAAV6-GFP reporter (as control) vectors were designed and prepared using an established protocol in our laboratory. PXL was performed using 10% gelatin and 10×106 hBMSCs/ml with different amount of rAAV6-GFP. Transfection efficiency was determined by counting GFP-positive cells ratio as well as assessing cell viability. At an optimal ratio, rAAV-BMP-2 and hBMSCs were included into gelatin through PXL. At different time point, BMP-2 production and rAAV6 release kinetics were analyzed. The osteogenesis of hBMSCs was assessed at day 28 by real time PCR and histological staining. In animal study, a 0.5 cm diameter critical size of cranial bone defect model was generated in SCID mice and then the constructs described above were transplanted. Micro-CT imaging and histological staining were used to evaluate the skull bone healing process up to 6 weeks. Results: Both rAAV and hBMSCs survived during the scaffold fabrication process. 10×104 rAAV/hBMSCs was shown to be the optimal ratio in maintaining cell viability and achieving transduction efficiency. After in situ transfection within scaffolds, hBMSCs produced higher BMP-2 amount than those subjected to traditional ex vivo transduction process, and underwent robust osteogenesis as well. In animal study, micro-CT imaging results indicated that rAAV BMP-2 & hBMSCs-activated gelatin scaffolds effectively promoted bone regeneration in mice cranial bone defect, in a manner significantly superior to that of scaffolds loaded with hBMSCs/BMP-2 protein, and was remarkably compatible to scaffolds loaded with hBMSCs previously ex vivo transduced by rAAV-BMP-2. The histological staining further confirmed the efficacious bone formation from rAAV BMP-2 & hBMSCs loaded scaffold. The results shown here thus demonstrate the feasibility of combining gene and cell therapy with biomaterial engineering via a single-step fabrication and its application for the repair of bone defect.

Effects of Recombinant Adeno-Associated Viral Vectors on Angiopoiesis and Osteogenesis in Cultured Rabbit Bone Marrow Stem Cells Via Co-Expressing Hvegf and Hbmp Genes: A Preliminary Study in Vitro

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

Angiopoiesis and Bone Regeneration Via Co-Expression of the Hvegf and Hbmp Genes from an Adeno-Associated Viral Vector in Vitro and in Vivo.

[Study on Biological Activity of Recombinant Adeno-Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor 165 and Human Bone Morphogenetic Protein 7 Genes in Vitro].

Rabbit bone marrow mesenchymal stem cells transfected with recombinant adenovirus vectors carrying basic fibroblast growth factor:variation of cell phenotypes

Raav-Mediated Angiogenin Gene Transfer Induces Angiogenesis and Modifies Left Ventricular Remodeling in Rats with Myocardial Infarction

Repair effects of co-expression of the VEGF and BMP genes via an adeno-associated viral vector on early steroid-in-duced avascular necrosis of the femoral head in rabbits

Repair effect of coexpression of the hVEGF and hBMP genes via an adeno-associated virus vector in a rabbit model of early steroid-induced avascular necrosis of the femoral head

The effects of recombinant adeno-associated virus vector co-expressing hVEGF165 and hBMP-7 genes in steroids-induced avascular necrosis of femoral head

524. Injectable BMP-2 Gene-Activated Scaffold for the Repair of Mouse Cranial Bone Defect

Enhancement of Bone Formation by Genetically-Engineered Bone Marrow Stromal Cells Expressing BMP-2, VEGF and Angiopoietin-1.

Hypoxia Induces Osteogenesis in Rabbit Adipose-Derived Stem Cells Overexpressing Bone Morphogenic Protein-2.

Effects of Different Ratios of BMP2 and VEGFA on the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells

Angiogenesis and bone regeneration by allogeneic mesenchymal stem cell intravenous transplantation in rabbit model of avascular necrotic femoral head.

Adenovirus-mediated expression of vascular endothelial growth factor-a potentiates bone morphogenetic protein9-induced osteogenic differentiation and bone formation

[Study of Adenovirus-Mediated Vascular Endothelial Growth Factor 165 Gene Transfer into Bone Marrow Stromal Cells and Its Expressive Product Promoting Proliferation of Endothelial Cells].

Construction of recombinant adeno-associated virus carrying human vascular endothelial growth factor 165 and in vitro infection of bone marrow mesenchymal stem cells

[Effects of BMP-2 Gene Therapy on Vascularization in Repairing Bone Defects].

Role of FGF-2 Transfected Bone Marrow Mesenchymal Stem Cells in Engineered Bone Tissue for Repair of Avascular Necrosis of Femoral Head in Rabbits

REPAIR OF RADIAL SEGMENTAL BONE DEFECTS BY COMBINED ANGIOPOIETIN 1 GENE TRANSFECTED BONE MARROW MESENCHYMAL STEM CELLS AND PLATELET-RICH PLASMA TISSUE ENGINEERED BONE IN RABBITS

Ectopic Bone Formation Using Bone Morphogenetic Protein 2 Adenoviral Vector